AI assistant
NUFARM LIMITED — Director's Dealing 2013
May 9, 2013
65453_rns_2013-05-09_111acafb-7ca1-4450-92f8-c8922e548586.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity NUFARM LIMITED ABN 37 091 323 312
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | WILLIAM BRUCE GOODFELLOW |
|---|---|
| Date of last notice | 16/11/2012 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct and Indirect |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to the relevantinterest. | Sulkem Company Ltd |
| Date of change | 10/05/2013 |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held prior to change | Direct:111,177 Fully Paid Ordinary SharesIndirect:Pacific Custodians Pty Ltd – 31,585 Fully PaidOrdinary SharesMA Goodfellow – 13,000 Fully Paid Ordinary Sharesand 100 NSSSt Kentigern Trust – 430,434 Fully Paid OrdinaryShares and 19,727 NSSSulkem Company Ltd – 121,373 Fully Paid OrdinarySharesAuckland Medical Research Foundation – 26,558NSSTrustees of The Goodfellow Foundation – 33,854Fully Paid Ordinary Shares and 1,338NSSWB Goodfellow and Edgar William Preston asTrustees of the 531 Trust – 400,861 FullyPaid Ordinary SharesArchem Trading (NZ) Ltd - 700 NSS |
|---|---|
| Class | Ordinary |
| Number acquired | Direct: 234 Fully Paid Ordinary SharesIndirect: (Sulkem Company Ltd) 898 Fully PaidOrdinary Shares |
| Number disposed | Nil |
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | $4.0569 |
| No. of securities held after change | Direct:111,411 Fully Paid Ordinary SharesIndirect:Pacific Custodians Pty Ltd – 31,585 Fully PaidOrdinary SharesMA Goodfellow – 13,000 Fully Paid Ordinary Sharesand 100 NSSSt Kentigern Trust – 430,434 Fully Paid OrdinaryShares and 19,727 NSSSulkem Company Ltd – 122,271 Fully Paid OrdinarySharesAuckland Medical Research Foundation – 26,558NSSTrustees of The Goodfellow Foundation – 33,854Fully Paid Ordinary Shares and 1,338NSSWB Goodfellow and Edgar William Preston asTrustees of the 531 Trust – 400,861 FullyPaid Ordinary SharesArchem Trading (NZ) Ltd - 700 NSS |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Nature of change Shares Issued under the Company’s Dividend Example: on-market trade, off-market trade, exercise of options, issue of Reinvestment Plan securities under dividend reinvestment plan, participation in buy-back
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change
Part 3 –[+] Closed period
| Part 3 –+Closed period | |
|---|---|
| Were the interests in the securities or contracts detailedabove traded during a+closed period where prior writtenclearance was required? | No |
| If so, was prior written clearance provided to allow the tradeto proceed during this period? | |
| If prior written clearance was provided, on what date was thisprovided? |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3